Zavegepant nasal spray in the acute treatment of migraine: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 11, doi. 10.1007/s40267-024-01130-4
- By:
- Publication type:
- Article
Works matching IS 11720360 AND DT 2025 AND VI 41 AND IP 1
Results: 7
1
2
New therapies for primary biliary cholangitis usher in a personalised approach to treatment.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 28, doi. 10.1007/s40267-024-01129-x
- By:
- Publication type:
- Article
3
Correction: Lotilaner ophthalmic solution 0.25% in Demodex blepharitis: a profile of its use.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
4
Nedosiran in primary hyperoxaluria type 1: a profile of its use: Nedosiran in primary hyperoxaluria type 1: a profile of its use: N.L. France, Y.Y. Syed.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 19, doi. 10.1007/s40267-024-01127-z
- By:
- Publication type:
- Article
5
Expanding the coverage of herpes zoster vaccination recommendations in European countries: the example of Portugal: Expanding the coverage of herpes zoster vaccination recommendations in Europe: S. Duque et al.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 34, doi. 10.1007/s40267-024-01126-0
- By:
- Publication type:
- Article
6
RSVPreF3 OA respiratory syncytial virus vaccine in older adults: a profile of its use: RSVPreF3 OA respiratory syncytial virus vaccine in older adults: M. Shirley.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 3, doi. 10.1007/s40267-024-01125-1
- By:
- Publication type:
- Article
7
Adis summary of research: Long-term safety and tolerability of daridorexant in patients with insomnia disorder.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 1, doi. 10.1007/s40267-024-01118-0
- By:
- Publication type:
- Article